Huberman Lab
Huberman Lab
Scicomm Media
Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity
1 hour 39 minutes Posted Aug 7, 2023 at 8:00 am.
In this episode, I explain how ketamine causes rewiring of brain circuits and dissociative states to relieve symptoms of depression and post-traumatic stress disorder (PTSD). I explain how ketamine impacts both the brain’s glutamate and its endogenous opioid pathways, which together regulate mood and well-being. I discuss how ketamine therapy is used clinically to treat major depression, bipolar depression, obsessive-compulsive disorder (OCD), suicidality and other psychiatric challenges. I also describe how ketamine causes the subjective effects of dissociation and euphoria and, at higher doses, is an anesthetic. I compare the different routes of ketamine administration, dosages and forms of ketamine, and if micro-dosing ketamine is effective. I also highlight the potential risks of recreational ketamine use (and the colloquial term ‘K-holes’). This episode should interest anyone interested in ketamine, treatments for depression, neuroplasticity mechanisms, psychiatry and mental health.For show notes, including referenced articles and additional resources, please visit hubermanlab.com.Use Ask Huberman Lab, our new AI-powered platform, for a summary, clips, and insights from this episode.Thank you to our sponsorsAG1: https://athleticgreens.com/hubermanLMNT: https://drinklmnt.com/hubermanlabWaking Up: https://wakingup.com/hubermanMomentous: https://livemomentous.com/hubermanTimestamps
Ketamine
Sponsors: LMNT & Waking Up
Ketamine & PCP; Clinical & Recreational Use
Depression & Current Treatments
Preclinical Models of Depression & Ketamine; “Learned Helplessness”
Ketamine & Clinical Uses; Depression & Suicidality
Ketamine & Other Psychiatric Challenges; Relief & Durability
Sponsor: AG1 (Athletic Greens)
NMDA Receptor & Neuroplasticity
Excitatory & Inhibitory Communication, Seizure, NMDA Receptors & Ketamine
How Ketamine Functions in Brain; Acute & Long-Term Effects
Brain-Derived Neurotrophic Factor (BDNF) & Ketamine Therapy
Ketamine & Opioid Pathway
Divergent Mechanisms of Immediate & Long-Term Effects
Habenula, Pro-Depressive Behaviors & Ketamine Therapy
Ketamine & Context-Dependent Strategy; Reward Pathway
Dissociative States
Doses & Routes of Administration; “K-holes”; Risk & Caution
Ketamine Forms; R-, S- vs R/S- Ketamine; Micro-Dosing
Ketamine: Effects & Therapy
0:00
1:39:56
Download MP3
Show notes
In this episode, I explain how ketamine causes rewiring of brain circuits and dissociative states to relieve symptoms of depression and post-traumatic stress disorder (PTSD). I explain how ketamine impacts both the brain’s glutamate and its endogenous opioid pathways, which together regulate mood and well-being. I discuss how ketamine therapy is used clinically to treat major depression, bipolar depression, obsessive-compulsive disorder (OCD), suicidality and other psychiatric challenges. I also describe how ketamine causes the subjective effects of dissociation and euphoria and, at higher doses, is an anesthetic. I compare the different routes of ketamine administration, dosages and forms of ketamine, and if micro-dosing ketamine is effective. I also highlight the potential risks of recreational ketamine use (and the colloquial term ‘K-holes’). This episode should interest anyone interested in ketamine, treatments for depression, neuroplasticity mechanisms, psychiatry and mental health.For show notes, including referenced articles and additional resources, please visit hubermanlab.com.Use Ask Huberman Lab, our new AI-powered platform, for a summary, clips, and insights from this episode.Thank you to our sponsorsAG1: https://athleticgreens.com/hubermanLMNT: https://drinklmnt.com/hubermanlabWaking Up: https://wakingup.com/hubermanMomentous: https://livemomentous.com/hubermanTimestamps(00:00:00) Ketamine(00:02:46) Sponsors: LMNT & Waking Up(00:05:13) Ketamine & PCP; Clinical & Recreational Use(00:09:00) Depression & Current Treatments(00:15:17) Preclinical Models of Depression & Ketamine; “Learned Helplessness” (00:22:11) Ketamine & Clinical Uses; Depression & Suicidality (00:28:32) Ketamine & Other Psychiatric Challenges; Relief & Durability (00:33:40) Sponsor: AG1 (Athletic Greens)(00:34:29) NMDA Receptor & Neuroplasticity(00:41:36) Excitatory & Inhibitory Communication, Seizure, NMDA Receptors & Ketamine(00:48:26) How Ketamine Functions in Brain; Acute & Long-Term Effects(00:55:36) Brain-Derived Neurotrophic Factor (BDNF) & Ketamine Therapy(01:03:40) Ketamine & Opioid Pathway (01:10:00) Divergent Mechanisms of Immediate & Long-Term Effects(01:15:45) Habenula, Pro-Depressive Behaviors & Ketamine Therapy(01:20:36) Ketamine & Context-Dependent Strategy; Reward Pathway(01:22:45) Dissociative States(01:26:04) Doses & Routes of Administration; “K-holes”; Risk & Caution(01:32:25) Ketamine Forms; R-, S- vs R/S- Ketamine; Micro-Dosing(01:38:24) Ketamine: Effects & Therapy(01:40:40) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous, Social Media, Neural Network NewsletterDisclaimer Learn more about your ad choices. Visit megaphone.fm/adchoices